| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 9.9% | $63,650,358 | 4,941,798 | TANG CAPITAL MANAGEMENT, LLC | 31 Mar 2025 | |||
| Frazier Life Sciences Public Fund, L.P. | 6.9% | +42% | $42,222,226 | +$12,986,864 | 3,466,521 | +44% | Frazier Life Sciences Public Fund, L.P. | 01 Nov 2025 |
| Capital World Investors | 6.4% | $40,927,321 | 3,177,587 | Capital World Investors | 31 Mar 2025 | |||
| MILLENNIUM MANAGEMENT LLC | 5.9% | +18% | $39,595,019 | +$5,780,725 | 2,963,699 | +17% | Millennium Management LLC | 23 Dec 2025 |
| Point72 Asset Management, L.P. | 5.5% | $44,930,777 | 2,781,902 | Point72 Asset Management, L.P. | 05 Jan 2026 | |||
| Vestal Point Capital, LP | 1.5% | $9,135,000 | 750,000 | Vestal Point Capital, LP | 30 Sep 2025 |
As of 31 Dec 2025, 160 institutional investors reported holding 66,956,279 shares of KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV). This represents 132% of the company’s total 50,580,036 outstanding shares.
The largest institutional shareholders of KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV) together control 112% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| VR ADVISER, LLC | 13% | 6,728,985 | 0% | 5.4% | $108,673,108 |
| Frazier Life Sciences Management, L.P. | 10% | 5,039,867 | 0% | 2.2% | $81,393,852 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 9.4% | 4,768,712 | 0% | 1.9% | $77,014,699 |
| TANG CAPITAL MANAGEMENT LLC | 9% | 4,573,530 | -9.3% | 3.6% | $73,862,510 |
| BlackRock, Inc. | 7.4% | 3,754,148 | +20% | 0% | $60,629,492 |
| MILLENNIUM MANAGEMENT LLC | 5.7% | 2,896,666 | +38% | 0.03% | $46,781,156 |
| Capital World Investors | 5.6% | 2,808,583 | -12% | 0.01% | $45,358,615 |
| VANGUARD GROUP INC | 5% | 2,509,020 | +0.32% | 0% | $40,520,674 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 4.8% | 2,427,118 | +78% | 5.7% | $39,197,956 |
| Point72 Asset Management, L.P. | 4.5% | 2,283,766 | 0.06% | $36,882,821 | |
| Woodline Partners LP | 3.8% | 1,921,092 | +0.02% | 0.12% | $31,025,636 |
| STATE STREET CORP | 3.8% | 1,911,691 | +21% | 0% | $30,873,810 |
| Vestal Point Capital, LP | 3.7% | 1,890,000 | +152% | 1.1% | $30,523,500 |
| Kynam Capital Management, LP | 3.6% | 1,810,954 | +199% | 1.9% | $29,246,907 |
| Parkman Healthcare Partners LLC | 3.5% | 1,768,508 | +1.9% | 2.7% | $28,561,404 |
| EMERALD ADVISERS, LLC | 2.7% | 1,340,495 | -0.8% | 0.67% | $21,648,994 |
| Octagon Capital Advisors LP | 2.5% | 1,273,333 | 0% | 2.6% | $20,564,328 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 2.3% | 1,171,755 | +1.1% | 0.01% | $18,923,843 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.9% | 944,077 | +1.7% | 0% | $15,251,132 |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1.7% | 855,461 | -6.8% | 0.67% | $13,815,695 |
| GOLDMAN SACHS GROUP INC | 1.7% | 835,304 | -54% | 0% | $13,490,160 |
| Elmind Capital, LP | 1.6% | 801,300 | 0% | 3.8% | $12,940,995 |
| ARMISTICE CAPITAL, LLC | 1.6% | 800,000 | 0.32% | $12,920,000 | |
| BARCLAYS PLC | 1.4% | 700,573 | +21% | 0% | $11,314,253 |
| MORGAN STANLEY | 1.4% | 700,227 | +24% | 0% | $11,308,665 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 66,956,279 | $1,081,355,139 | +$110,690,698 | $16.15 | 160 |
| 2025 Q3 | 58,631,949 | $714,167,775 | +$51,926,556 | $12.18 | 144 |
| 2025 Q2 | 54,445,883 | $615,513,091 | -$5,352,606 | $11.30 | 138 |
| 2025 Q1 | 54,890,685 | $633,782,153 | +$5,364,849 | $11.54 | 127 |
| 2024 Q4 | 55,190,249 | $467,414,520 | +$30,397,001 | $8.47 | 129 |
| 2024 Q3 | 48,412,221 | $560,958,769 | +$549,019 | $11.58 | 120 |
| 2024 Q2 | 48,235,227 | $568,211,775 | +$14,329,598 | $11.78 | 118 |
| 2024 Q1 | 46,978,393 | $557,162,578 | +$117,921,974 | $11.86 | 128 |
| 2023 Q4 | 36,983,052 | $453,043,903 | +$5,790,575 | $12.25 | 92 |
| 2023 Q3 | 36,263,336 | $349,220,877 | +$17,912,528 | $9.63 | 101 |
| 2023 Q2 | 34,451,516 | $310,062,547 | +$8,864,955 | $9.00 | 93 |
| 2023 Q1 | 33,720,468 | $265,039,035 | -$7,240,065 | $7.86 | 87 |
| 2022 Q4 | 33,810,837 | $228,557,857 | +$23,549,577 | $6.76 | 88 |
| 2022 Q3 | 25,639,454 | $372,024,783 | +$16,611,056 | $14.51 | 88 |
| 2022 Q2 | 24,252,971 | $238,647,172 | -$18,209,799 | $9.84 | 84 |
| 2022 Q1 | 23,950,478 | $353,046,504 | -$11,733,222 | $14.74 | 84 |
| 2021 Q4 | 23,784,064 | $314,614,009 | -$24,155,895 | $13.23 | 93 |
| 2021 Q3 | 23,380,949 | $408,241,803 | -$21,548,932 | $17.45 | 101 |
| 2021 Q2 | 24,320,398 | $582,722,986 | +$12,095,008 | $23.96 | 108 |
| 2021 Q1 | 23,504,843 | $603,806,496 | +$241,335,972 | $25.69 | 115 |
| 2020 Q4 | 14,665,664 | $278,488,932 | +$4,362,596 | $18.99 | 79 |
| 2020 Q3 | 16,200,799 | $203,913,450 | +$2,818,589 | $12.59 | 61 |
| 2020 Q2 | 15,986,858 | $193,667,544 | +$9,419,888 | $12.10 | 72 |
| 2020 Q1 | 15,660,431 | $119,795,221 | +$17,243,054 | $7.65 | 68 |
| 2019 Q4 | 13,721,637 | $244,359,076 | +$13,370,440 | $17.81 | 73 |
| 2019 Q3 | 13,183,569 | $152,927,098 | -$33,989,311 | $11.60 | 75 |
| 2019 Q2 | 14,786,402 | $327,505,666 | +$6,277,733 | $22.15 | 74 |
| 2019 Q1 | 13,905,857 | $397,892,000 | +$23,850,655 | $28.62 | 67 |
| 2018 Q4 | 12,995,790 | $256,399,000 | +$7,695,219 | $19.75 | 56 |
| 2018 Q3 | 12,319,459 | $272,385,000 | +$112,676,598 | $22.11 | 46 |
| 2018 Q2 | 6,316,266 | $51,280,000 | -$1,600,370 | $8.12 | 24 |
| 2018 Q1 | 6,502,232 | $61,590,000 | +$133,882 | $9.48 | 23 |
| 2017 Q4 | 6,484,043 | $63,213,000 | -$2,998,314 | $9.75 | 23 |
| 2017 Q3 | 7,715,060 | $52,230,000 | +$2,314,839 | $6.73 | 15 |
| 2017 Q2 | 7,368,527 | $54,075,000 | -$1,766,461 | $7.36 | 17 |
| 2017 Q1 | 7,587,480 | $59,162,000 | +$2,023,038 | $7.81 | 18 |
| 2016 Q4 | 7,331,083 | $51,493,000 | +$46,974,000 | $7.07 | 18 |